Trial intelligence / Profile preview

Vardenafil Nasal Instillation in Cystic Fibrosis

NCT01002534Phase 2Terminated

Start
Oct 2011
Primary completion
Jun 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of vardenafil in cystic fibrosis (CF). Started Oct 2011; status: terminated.

02

Drugs

vardenafil
03

Conditions

cystic fibrosis (CF)

Beyond the preview

Go deeper on NCT01002534.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01002534.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call